Childhood brain meningioma

Summary

Childhood brain meningioma (MONDO:0004046) is a disease and 1 clinical trial. A subtype of pediatric meningioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood brain meningioma
Mondo ID	MONDO:0004046
DOID	DOID:6939
NCIT	C6253
UMLS	C1332949
MedGen	234122
GARD	0023790
Anatomy (UBERON)	UBERON:0000955
Is cancer (heuristic)	no

Also known as: Brain meningioma · brain paediatric meningioma · brain pediatric meningioma · childhood meningioma of brain · childhood meningioma of the brain · paediatric brain meningioma · paediatric meningioma of brain · paediatric meningioma of the brain · pediatric brain meningioma · pediatric meningioma of the brain

Disease family

This is a subtype of pediatric meningioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › tumor of meninges › meningioma › pediatric meningioma › childhood brain meningioma

Related subtypes (1): pediatric leptomeningeal melanoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04710485	Not specified	UNKNOWN	Sphenoorbital Meningioma Management.